期刊
JOURNAL OF NEUROLOGY
卷 268, 期 9, 页码 3135-3143出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00415-020-09810-7
关键词
Levodopa challenge test; Parkinson's disease; DBS screening; Levodopa responsiveness; Levodopa unresponsiveness; Short-duration response
资金
- Parkinson's Foundation
This paper discusses the importance of drug challenge test in Parkinson's disease, especially the levodopa challenge test, and provides an overview of the different indications, commonly used protocols, and responsiveness or unresponsiveness to levodopa. Potential complications of the procedure are also highlighted.
A drug challenge test in Parkinson's disease, such as the levodopa challenge test (LCT), is an easy and generally safe procedure, which has been used by clinicians for various indications. The results of the test have significant implications in the management of patients, from preoperative evaluation for deep brain stimulation to providing the basis for medication adjustments to address motor or non-motor fluctuations and dyskinesias. This paper reviews the different indications and protocols commonly used in an acute LCT. Potential complications of the procedure and an overview of levodopa responsiveness and unresponsiveness are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据